References
- Bakke O. M., Wardell W. M., Lasagna L. Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safety. Clinical and Pharmacological Therapeutics 1984; 35: 559–567
- Campbell R. M., Cuthbertson D. P., Matthews C. M., McFarlane A. S. Behaviour of 14C- and 131I-labelled plasma proteins in the rat. International Journal of Radiation Isotopes 1956; 1: 66–84
- Faed E. M. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metabolism Reviews 1984; 15: 1213–1249
- Gautam A., Seligson H., Gordon E. R., Seilgson D., Boyer J. L. Irreversible binding of conjugated bilirubin to albumin in cholestatic rats. Journal Clinical Investigation 1984; 73: 873–877
- Gillette J. R. Significance of covalent binding of chemically reactive metabolites of foreign compounds to proteins and lipids. Biological Reactive Intermediates III, J. J. Kocsis, D. J. Jollow, C. M. Witmer, J. O. Nelson, R. Snyder. Plenum, New York 1985; 63–82
- Hart D., Ward M., Lifschitz M. D. Suprofen related nephrotoxicity. Annals of Internal Medicine 1987; 106: 235–238
- Hyneck M. L., Smith P. C., Munafo A., McDonagh A. F., Benet L. Z. Disposition and irreversible plasma protein binding of tolmetin in humans. Journal of Clinical Pharmacology 1988; 44: 107–114
- King A. R., Dickinson R. G. Studies on the reactivity of acyl glucuronides-IV. Covalent binding of diflunisal to tissues of the rat. Biochemical Pharmacology 1993; 45: 1043–1047
- Kretz-Rommel A., Boelsterli U. A. Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes. Toxicology and Applied Pharmacology 1993; 120: 155–161
- McDonagh A. F., Palma L. A., Lauff J. J., Wu T.-W. Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat. Journal of Clinical Investigation 1984; 74: 763–770
- McKinnon G. E., Dickinson R. G. Covalent binding of diflunisal and probenecid to plasma protein in humans: persistence of the adducts in the circulation. Research Communications in Chemical Pathology and Pharmacology 1989; 66: 339–354
- Mori Y., Kuroda N., Sakai Y., Yokay F., Toyoshi K., Baba S. Species differences in the metabolism of suprofen in laboratory animals and man. Drug Metabolism Disposition 1985; 13: 239–245
- Reed R. G., Davidson L. K., Burrington C. M., Peters T. Non-resolving jaundice: Bilirubin covalently attached to serum albumin circulates with same metabolic half-life as albumin. Clinical Chemistry 1988; 34: 1992–1994
- Rowe B. J., Meffin P. J. Diisopropylfluorophosphate increases clofibric acid clearance: supporting evidence for a futile cycle. Journal of Pharmacology and Experimental Therapeutics 1984; 230: 237–241
- Sallustio B. C., Knights K. M., Roberts B. J., Zacest R. In vivo covalent binding of clofibric acid to human plasma proteins and rat liver proteins. Biochemical Pharmacology 1991; 42: 1421–1425
- Smith P. C., McDonagh A. F., Benet L. Z. Irreversible binding of zomepirac to plasma proteins in vitro and in vivo. Journal of Clinical Investigation 1986; 77: 934–939
- Smith P. C., Benet L. Z., McDonagh A. F. Covalent binding of zomepirac glucuronide proteins: evidence for a Schiff base mechanism. Drug Metabolism and Disposition 1990a; 18: 639–644
- Smith P. C., Liu J. H. Covalent binding of suprofen acyl glucuronide to albumin in vitro. Xenobiotica 1993; 23: 337–348
- Smith P. C., McDonagh A. F., Benet L. Z. Effect of esterase inhibition on the disposition of zomepirac glucuronide and its covalent binding to plasma proteins in the guinea pig. Journal of Pharmacology and Experimental Therapeutics 1990b; 252: 218–224
- Spahn-Langguth H., Benet L. Z. Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism. Drug Metabolism Reviews 1992; 24: 5–48
- Strom B. L., West S. L., Sim E., Carson J. L. The epidemiology of the acute flank pain syndrome from suprofen. Clinical Pharmacology and Therapeutics 1989; 46: 693–699
- Van Breeman R. B., Fenselau C. C. Reactions of 1-O-acyl glucuronides with 4-(p-nitroben-zyl)pyridine. Drug Metabolism and Disposition 1986; 14: 197–201
- Volland C., Sun H., Dammeyer J., Benet L. Z. Stereoselective degradation of fenoprofen acyl glucuronide enantiomers and irreversible binding to plasma protein. Drug Metabolism and Disposition 1991; 19: 1080–1086
- Watt J. A., Dickinson R. G. Reactivity of diflunisal acyl glucuronide in human and rat plasma and albumin solutions. Biochemical Pharmacology 1990; 39: 1067–1075